|
|
|
|
||
Cowen first page of $PFE Pfizer report: Key pipeline products include abrocitinib (JAK1i) in Phase III for AD; #SB525 (with $SGMO Sangamo) #genetherapy for hemophilia A in Phase II; and 20v pneumococcal vaccine (in Phase III) read-outs will be key to mul |
return to message board, top of board |